基本信息
浏览量:1
职业迁徙
个人简介
My major research pursuits are related to development of novel therapeutics based on knowledge of cellular responses to DNA damage, and elucidating the mechanisms of drug action, particularly of nucleoside analogs. Investigations by my group demonstrated multiple mechanism of action for both fludarabine and gemcitabine, as well as the mechanisms of other nucleosides. I have enjoyed sustained and dedicated collaborations with his colleagues involved with clinical research, interactions that have resulted in advances in clinical treatments that induce remissions more effectively and are maintained them longer than previously possible in leukemias. I was the recipient of the Service to Mankind Award from the Leukemia Society of America in 1989, the Faculty Achievement Award in Clinical Research in 1996, and the 1 st Potu N. Rao award for Excellence in Basic Research in 2006, and the Waun Ki Hong Achievement Award for Team Research - CLL in 2011. I was elected a Fellow of the American Association for the Advancement of Science in 2012. I was the 2013 recipient of the Charles A. LeMaistre, M.D. Outstanding Acheivement Award in Cancer and received the John Mendelsohn Lifetime Scientific Achievement Award in 2016. Under the title of Associate Vice President, Research Integrity, I have assumed the responsibilities of the Institutional Research Integrity Officer since 2007.
研究兴趣
论文共 592 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 518-518
Xiaojun Liu, Ying Guo,Yexiong Li,Yingjun Jiang, Sherri Chubb,Atsushi Azuma,Peng Huang,Akira Matsuda, Walter Hittelman,William Plunkett
crossref(2023)
BLOOD (2023)
Xiaojun Liu, Ying Guo,Yexiong Li,Yingjun Jiang, Sherri Chubb,Atsushi Azuma,Peng Huang,Akira Matsuda, Walter Hittelman,William Plunkett
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn